Metastatic breast cancer is breast cancer that has spread beyond the breast and to the other parts of the body, it’s still breast cancer and treated as breast cancer. Recently a campaign to encourage the patients of Metastatic breast cancer to take up clinical trial was announced by The Metastatic Breast Cancer Alliance (MBCA) just before the launch of MBC Connect 2.0.
In an interview by CURE, Shirley A. Mertz, chairperson of the MBCA and a patient of Metastatic breast cancer herself shared the aims and objectives of this campaign. She said that MBCA is working towards helping patients to get through the procedures of Metastatic breast cancer treatment easily. Patients of Metastatic breast cancer are always in treatment, and since it is an incurable disease, the oncologists face the problems of what treatment to use next. So more and more patients are encouraged to participate in clinical trials so that new treatments can be found out and the disease can be cured accordingly.
Considering patients have a problem in finding out different kinds of trials, Dr.Shirley suggested the website Clinicaltrials.gov that lists all of the trials that are going on in the United States. She further informed about the two-page brochure called ‘Patient Clinical Trial Checklist’ on their website that comprises of 10 questions that a patient should ask their oncologist and understand the answer before they make a decision about joining a trial.
The MBC Connect 2.O program offers patients with the opportunity to obtain information that instructs them about their disease history and take into account what treatments they had. The program is presented to them in such a way where it is easy to understand what is being studied and what they will be expected to do if they participate.